Sounds pretty good to me, break even this year, slight delay on the finalising of the hernia production, breast augmentation will now run in parallel to Hernia stuff, new product for tendon and meniscus repair, all up pretty good I reckon.
Ann: Appendix 4E and FY20 Annual Report, page-2
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.99 |
Change
-0.100(4.78%) |
Mkt cap ! $1.373B | |||
| Open | High | Low | Value | Volume |
| $2.04 | $2.06 | $1.99 | $3.800M | 1.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 18617 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.00 | 1911 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.00 |
Change
-0.100 ( 5.06 %) |
||||
| Open | High | Low | Volume | ||
| $2.04 | $2.06 | $2.00 | 513328 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| PNV (ASX) Chart |